Log In
Print
BCIQ
Print
Print this Print this
 

rHA vaccine

  Manage Alerts
Collapse Summary General Information
Company Royal DSM N.V.
DescriptionVaccine comprising a recombinant hemagglutinin (rHA) protein derived from the A/Puerto Rico/8/34 strain of the H1N1 influenza virus expressed in Schizochytrium microbial algae
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard Indication Infectious (unspecified)
Indication DetailsVaccinate against H1N1 influenza virus infection
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today